A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 Regulation.

Int J Mol Sci · 2023 · PMC9959061 · PMID 36835354

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The other steatogenic molecules failed to induce a significant steatosis with the StAZ, but they showed a trend towards an increase, notably for amiodarone and valproate.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.